Skip to main content

Table 4 Total transfusion amounts received by patients

From: The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study

 

rhTM group

Control group

P valuea

 

(n = 37)

(n = 28)

RBC, units, mean (median)

   

 Non-adjusted

5.65 (4.00)

4.83 (2.00)

0.164

 Adjusted

4.90 (4.00)

5.62 (4.00)

0.876

FFP, units, mean (median)

   

 Non-adjusted

7.73 (5.00)

5.93 (5.00)

0.360

 Adjusted

7.02 (5.00)

6.65 (5.00)

0.537

PC, units, mean (median)

   

 Non-adjusted

3.11 (0.00)

6.21 (0.00)

0.098

 Adjusted

3.02 (0.00)

6.03 (0.00)

0.016

Fibrinogen, g, mean (median)

   

 Non-adjusted

0.32 (0.00)

0.17 (0.00)

0.822

 Adjusted

0.49 (0.00)

0.22 (0.00)

0.706

  1. Data are expressed as group mean (median). a P value between the two groups in the Kruskal–Wallis test. RBC red blood cells, FFP fresh frozen plasma, PC platelet concentrate